PunjiPUNJI
Live AI ↗
Pharmaceuticals & BiotechnologyMid Cap

GlaxoSmithkline Pharmaceuticals Ltd.

GLAXO · ISIN: INE159A01016

Constituent of NIFTY 100 TRI (0.11%), NIFTY 500 TRI (0.05%), NIFTY LMC 250 TRI (0.13%), NIFTY MC 150 TRI (0.26%)

Close (as of 2026-09-08)
₹2928.2
-1% today
Day Range
₹2921.2 - ₹3001.3
Quality Score (as of 2026-06-30)
80/100

Earnings (TTM)

CHART

GlaxoSmithkline Pharmaceuticals Ltd. - revenue & profit (TTM)

Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.

0 Cr110738 Cr221477 Cr332215 Cr442953 CrQ2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue (TTM)PAT (TTM)

36.73%

EBITDA Margin (TTM)

62.01

EPS (TTM)

23.29%

EPS Growth (5Y)

10.87%

EPS Growth (10Y)

Technicals

57.3

RSI (14)

2679.32

SMA (50)

2486.18

SMA (200)

37.16

ADX (14)

3120.7

52-Week High

2088.1

52-Week Low

6.39%

1Y Return

58.2282

Avg Traded Value (20D, ₹Cr)

As of 2026-09-08.

Shareholding Pattern

CHART

Shareholding by category

As of 2026-06-30.

75%25%TOP 2100%
Promoter 75%Public 25%

F&O Sentiment

Nearest expiry: 2012-09-27 · As of 2012-09-27.

0

PCR (OI)

-

PCR (Volume)

1350

Max Pain Strike

Corporate Actions

Ex-DateTypeRatioDetails
2018-09-11BONUS0.500000 BONUS 1:1

Recent Deals

No recent block/bulk/short-sell deals on record for this stock.

Stock data · Not financial advice · Past performance does not indicate future returns